Jun Lu - Profile and Investment Details

Find investors who align with your industry, stage, and vision. Unlock Jun Lu’s full investment profile, including location, investment focus, portfolio companies, and preferences. Sign up today and start building investor relationships that fuel your startup’s growth.

Get connected with all investors today
img
Investor type:
City/Area:

Social media:

Past investments:

  • Ansun Biopharma, Inc.
  • Jiangsu Hengrui Pharmaceuticals Co., Ltd.

Investor Profile

Jun Lu is a Venture Capital based in Houston, Texas, United States with a diverse investment portfolio that includes companies such as Ansun Biopharma, Inc., Jiangsu Hengrui Pharmaceuticals Co., Ltd., . Over time, Jun Lu has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Jun Lu is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Patient Care, Health Care, Research and Development, Drug Discovery, Wellness, Immunotherapy, Healthcare Innovation, Emerging Markets, Health Technology, Medical Technologies, Health Care Policy, Manufacturing, Biotechnology, Medical Devices, Drug Development, Precision Medicine, Clinical Trials, Research, Licensing, Regulatory Compliance, Nanotechnology, Medical, B2B, Pharmaceuticals, Healthcare Technology, Oncology may find it worthwhile to explore potential connections with Jun Lu, as their portfolio suggests a familiarity and interest in this area.

Understanding Jun Lu’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.

Finally raise your round with Angel Match

Angel Match is the easiest way to research investors for your startup so you can spend less time Googling and more time raising.

Find the perfect investors today